This site is intended for Healthcare professionals only.
Elsevier-Clinicalkey

U.S. judge dismisses Teva lawsuits against Lilly on migraine drug


U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

BOSTON: A federal judge recently dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly and Co from bringing its migraine drugEmgality to market in the United States.

U.S. District Judge Allison Burroughs in Boston said the lawsuits failed to raise an actual controversy that would allow her to rule in advance of the U.S. Food and Drug Administration’s approving Lilly’s product on whether it infringed Teva’s patents.

The FDA approved Teva’s own migraine drug, Ajovy, on Sept. 14.

Representatives for the companies did not immediately respond to requests for comment.

Read Also: Dr Reddy’s loses a patent case with Eli Lilly over Alimta



Source: Reuters
0 comment(s) on U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted